- Home
- XBP vs DYAI Comparison
XBP vs DYAI Comparison
Compare XBP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- DYAI
- Stock Information
- Founded
- XBP N/A
- DYAI 1979
- Country
- XBP United Kingdom
- DYAI United States
- Employees
- XBP N/A
- DYAI N/A
- Industry
- XBP Business Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XBP Consumer Discretionary
- DYAI Health Care
- Exchange
- XBP Nasdaq
- DYAI Nasdaq
- Market Cap
- XBP 32.2M
- DYAI 31.3M
- IPO Year
- XBP N/A
- DYAI 2004
- Fundamental
- Price
- XBP $1.02
- DYAI $1.01
- Analyst Decision
- XBP
- DYAI Strong Buy
- Analyst Count
- XBP 0
- DYAI 1
- Target Price
- XBP N/A
- DYAI $6.00
- AVG Volume (30 Days)
- XBP 34.2K
- DYAI 40.5K
- Earning Date
- XBP 05-15-2025
- DYAI 05-14-2025
- Dividend Yield
- XBP N/A
- DYAI N/A
- EPS Growth
- XBP N/A
- DYAI N/A
- EPS
- XBP N/A
- DYAI N/A
- Revenue
- XBP $142,332,000.00
- DYAI $3,554,344.00
- Revenue This Year
- XBP N/A
- DYAI $78.01
- Revenue Next Year
- XBP N/A
- DYAI N/A
- P/E Ratio
- XBP N/A
- DYAI N/A
- Revenue Growth
- XBP N/A
- DYAI 57.59
- 52 Week Low
- XBP $0.79
- DYAI $0.93
- 52 Week High
- XBP $2.27
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- XBP 44.62
- DYAI 43.58
- Support Level
- XBP $1.01
- DYAI $0.95
- Resistance Level
- XBP $1.13
- DYAI $1.13
- Average True Range (ATR)
- XBP 0.08
- DYAI 0.08
- MACD
- XBP -0.01
- DYAI 0.01
- Stochastic Oscillator
- XBP 27.27
- DYAI 53.10
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.